Inventor · disambiguated record
Jacques J. Peschon
Also filed as: PESCHON JACQUES · PESCHON JACQUES J · PESCHON JACQUES JEAN
11 granted patents·13 pending applications·248 citations·filing 2001–2023
93Inventor score
Top patents by PatentIndex Score
24 records- 0197US7939070B2IL-17 receptor A antigen binding proteinsAMGEN INC·Filed 2007·Granted May 10, 2011·46 cites·32 claims
- 0297US7833527B2Methods of treating psoriasis using IL-17 Receptor A antibodiesAMGEN INC·Filed 2007·Granted Nov 16, 2010·57 cites·22 claims
- 0397US7786284B2Polynucleotides encoding IL-17 receptor A antigen binding proteinsAMGEN INC·Filed 2007·Granted Aug 31, 2010·50 cites·52 claims
- 0496US8790648B2Methods of treating psoriasis using IL-17 receptor A antibodiesTOCKER JOEL·Filed 2012·Granted Jul 29, 2014·27 cites·59 claims
- 0594US8545842B2Polynucleotides encoding IL-17 receptor A antigen binding proteinsTOCKER JOEL·Filed 2010·Granted Oct 1, 2013·19 cites·32 claims
- 0694US8435518B2Methods of using IL-17 receptor a antibodiesTOCKER JOEL·Filed 2010·Granted May 7, 2013·23 cites·65 claims
- 0791US9096673B2IL-17 receptor A antigen binding proteinsTOCKER JOEL·Filed 2011·Granted Aug 4, 2015·10 cites·32 claims
- 0889US2024294652A1Il-17 receptor a antigen binding proteinsAMGEN K A INC·Filed 2023·Application pending·0 cites
- 0988US10208122B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2016·Granted Feb 19, 2019·4 cites·5 claims
- 1080US7122183B2Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30LIMMUNEX CORP·Filed 2003·Granted Oct 17, 2006·12 cites·23 claims
- 1175US11858999B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2020·Granted Jan 2, 2024·0 cites·4 claims
- 1273US11180564B2IL-17 Receptor A antigen binding proteinsAMGEN K A INC·Filed 2018·Granted Nov 23, 2021·0 cites·3 claims
- 1368US2014356355A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2014·Application pending·0 cites
- 1467US2010028345A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2007·Application pending·0 cites
- 1566US2010071079A1Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30lIMMUNEX CORP·Filed 2009·Application pending·0 cites
- 1660US2008213259A1Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30LIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 1755US2011008356A1Il-17 heteromeric receptor complexAMGEN INC·Filed 2008·Application pending·0 cites
- 1853US2009247605A1Treating diseases mediated by metalloprotease-shed proteinsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 1949US2013004969A1IL-17 Heteromeric Receptor ComplexAMGEN INC·Filed 2012·Application pending·0 cites
- 2048US2003027334A1Method for generating immortal dendritic cell linesFiled 2002·Application pending·0 cites
- 2146US2003108959A1Treating diseases mediated by metalloprotease-shed proteinsFiled 2002·Application pending·0 cites
- 2244US2003087411A1Death associated kinase containing ankyr in repeats (DAKAR) and methods of useFiled 2002·Application pending·0 cites
- 2343US2002132342A1Method for generating immortal dendritic cell linesFiled 2001·Application pending·0 cites
- 2439US2002182656A1Methods for regulating vascularization using GEF containing NEK-like kinase (GNK)Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacques J. Peschon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →